Lats2 Modulates Adipocyte Proliferation and Differentiation via Hippo Signaling

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  An, Yang ^a   Kang, Qianqian ^a   Zhao, Yaofeng ^a   Hu, Xiaoxiang ^a   Li, Ning ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DISHEVELLED 2; HIPPO PROTEIN; LATS2 PROTEIN; LEF PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOTRANSFERASE; REGULATOR PROTEIN; T CELL FACTOR PROTEIN; TAZ PROTEIN; TEAD PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; YAP PROTEIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; WNT SIGNALING PATHWAY;

3T3-L1 CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOPLASM; MICE; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; WNT SIGNALING PATHWAY;

EID: 84881582195     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072042     Document Type: Article

References (58)

1. Pan D, (2010) The hippo signaling pathway in development and cancer. Dev Cell 19: 491-505.
2. Codelia VA, Irvine KD, (2012) Hippo signaling goes long range. Cell 150: 669-670.
3. Zhao B, Li L, Lei Q, Guan KL, (2010) The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev 24: 862-874.
4. Zhao B, Wei X, Li W, Udan RS, Yang Q, et al. (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21: 2747-2761.
5. Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, et al. (2008) TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol 28: 2426-2436.
6. Zhao B, Lei QY, Guan KL, (2008) The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol 20: 638-646.
7. Zhao B, Ye X, Yu J, Li L, Li W, et al. (2008) TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22: 1962-1971.
8. Cao X, Pfaff SL, Gage FH, (2008) YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes Dev 22: 3320-3334.
9. Matsui Y, Nakano N, Shao D, Gao S, Luo W, et al. (2008) Lats2 is a negative regulator of myocyte size in the heart. Circ Res 103: 1309-1318.
10. Takahashi Y, Miyoshi Y, Takahata C, Irahara N, Taguchi T, et al. (2005) Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Clin Cancer Res 11: 1380-1385.
11. Jiang Z, Li X, Hu J, Zhou W, Jiang Y, et al. (2006) Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma. Neurosci Res 56: 450-458.
12. Li Y, Pei J, Xia H, Ke H, Wang H, et al. (2003) Lats2, a putative tumor suppressor, inhibits G1/S transition. Oncogene 22: 4398-4405.
13. Yabuta N, Okada N, Ito A, Hosomi T, Nishihara S, et al. (2007) Lats2 is an essential mitotic regulator required for the coordination of cell division. J Biol Chem 282: 19259-19271.
14. McPherson JP, Tamblyn L, Elia A, Migon E, Shehabeldin A, et al. (2004) Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity. EMBO J 23: 3677-3688.
15. Cai J, Zhang N, Zheng Y, de Wilde RF, Maitra A, et al. (2010) The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev 24: 2383-2388.
16. Lee KP, Lee JH, Kim TS, Kim TH, Park HD, et al. (2010) The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci U S A 107: 8248-8253.
17. Lu L, Li Y, Kim SM, Bossuyt W, Liu P, et al. (2010) Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci U S A 107: 1437-1442.
18. von Gise A, Lin Z, Schlegelmilch K, Honor LB, Pan GM, et al. (2012) YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc Natl Acad Sci U S A 109: 2394-2399.
19. Gregoire FM, Smas CM, Sul HS, (1998) Understanding adipocyte differentiation. Physiol Rev 78: 783-809.
20. Guilherme A, Virbasius JV, Puri V, Czech MP, (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9: 367-377.
21. Lean ME, (2000) Pathophysiology of obesity. Proc Nutr Soc 59: 331-336.
22. Gesta S, Tseng YH, Kahn CR, (2007) Developmental origin of fat: tracking obesity to its source. Cell 131: 242-256.
23. Grimaldi PA, (2001) The roles of PPARs in adipocyte differentiation. Prog Lipid Res 40: 269-281.
24. Prestwich TC, Macdougald OA, (2007) Wnt/beta-catenin signaling in adipogenesis and metabolism. Curr Opin Cell Biol 19: 612-617.
25. Suh JM, Gao X, McKay J, McKay R, Salo Z, et al. (2006) Hedgehog signaling plays a conserved role in inhibiting fat formation. Cell Metab 3: 25-34.
26. Bost F, Aouadi M, Caron L, Binetruy B, (2005) The role of MAPKs in adipocyte differentiation and obesity. Biochimie 87: 51-56.
27. Gimble JM, Morgan C, Kelly K, Wu X, Dandapani V, et al. (1995) Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells. J Cell Biochem 58: 393-402.
28. He Q, Huang HY, Zhang YY, Li X, Qian SW, et al. (2012) TAZ is downregulated by dexamethasone during the differentiation of 3T3-L1 preadipocytes. Biochem Biophys Res Commun 419: 573-577.
29. Student AK, Hsu RY, Lane MD, (1980) Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J Biol Chem 255: 4745-4750.
30. Guo X, Liao K, (2000) Analysis of gene expression profile during 3T3-L1 preadipocyte differentiation. Gene 251: 45-53.
31. Peng Y, Zheng Y, Zhang Y, Zhao J, Chang F, et al. (2012) Different effects of omega-3 fatty acids on the cell cycle in C2C12 myoblast proliferation. Mol Cell Biochem 367: 165-173.
32. Varelas X, Miller BW, Sopko R, Song S, Gregorieff A, et al. (2010) The Hippo pathway regulates Wnt/beta-catenin signaling. Dev Cell 18: 579-591.
33. Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, et al. (2005) TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309: 1074-1078.
34. Ota M, Sasaki H, (2008) Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development 135: 4059-4069.
35. Dong J, Feldmann G, Huang J, Wu S, Zhang N, et al. (2007) Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130: 1120-1133.
36. Rosen ED, MacDougald OA, (2006) Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7: 885-896.
37. Chen Z, Torrens JI, Anand A, Spiegelman BM, Friedman JM, (2005) Krox20 stimulates adipogenesis via C/EBPbeta-dependent and-independent mechanisms. Cell Metab 1: 93-106.
38. Oishi Y, Manabe I, Tobe K, Tsushima K, Shindo T, et al. (2005) Kruppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab 1: 27-39.
39. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM, (2000) Transcriptional regulation of adipogenesis. Genes Dev 14: 1293-1307.
40. Huang C, Zhang Y, Gong Z, Sheng X, Li Z, et al. (2006) Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway. Biochem Biophys Res Commun 348: 571-578.
41. Fajas L, Egler V, Reiter R, Hansen J, Kristiansen K, et al. (2002) The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation. Dev Cell 3: 903-910.
42. Park SK, Oh SY, Lee MY, Yoon S, Kim KS, et al. (2004) CCAAT/enhancer binding protein and nuclear factor-Y regulate adiponectin gene expression in adipose tissue. Diabetes 53: 2757-2766.
43. Siersbaek R, Nielsen R, Mandrup S, (2010) PPARgamma in adipocyte differentiation and metabolism-novel insights from genome-wide studies. FEBS Lett 584: 3242-3249.
44. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, et al. (2000) Inhibition of adipogenesis by Wnt signaling. Science 289: 950-953.
45. Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, et al. (2002) Regulation of Wnt signaling during adipogenesis. J Biol Chem 277: 30998-31004.
46. Clevers H, (2006) Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
47. Galceran J, Sustmann C, Hsu SC, Folberth S, Grosschedl R, (2004) LEF1-mediated regulation of Delta-like1 links Wnt and Notch signaling in somitogenesis. Genes Dev 18: 2718-2723.
48. Filali M, Cheng N, Abbott D, Leontiev V, Engelhardt JF, (2002) Wnt-3A/beta-catenin signaling induces transcription from the LEF-1 promoter. J Biol Chem 277: 33398-33410.
49. Tetsu O, McCormick F, (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426.
50. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, et al. (1998) Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
51. Zhang T, Otevrel T, Gao Z, Ehrlich SM, Fields JZ, et al. (2001) Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61: 8664-8667.
52. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, et al. (2002) Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22: 1172-1183.
53. Jackson A, Vayssiere B, Garcia T, Newell W, Baron R, et al. (2005) Gene array analysis of Wnt-regulated genes in C3H10T1/2 cells. Bone 36: 585-598.
54. Cawthorn WP, Heyd F, Hegyi K, Sethi JK, (2007) Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin/TCF4(TCF7L2)-dependent pathway. Cell Death Differ 14: 1361-1373.
55. Zhao B, Tumaneng K, Guan KL, (2011) The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 13: 877-883.
56. Liu Q, Gu X, Zhao Y, Zhang J, Meng Q, et al. (2010) Pig large tumor suppressor 2 (Lats2), a novel gene that may regulate the fat reduction in adipocyte. BMB Rep 43: 97-102.
57. Malumbres M, Barbacid M, (2005) Mammalian cyclin-dependent kinases. Trends Biochem Sci 30: 630-641.
58. Duman-Scheel M, Weng L, Xin S, Du W, (2002) Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E. Nature. 417: 299-304.